MYND Life Sciences Inc.
OTC: MYNDF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wilfred A. Jefferies
- Headquarters
- Kelowna, Canada
- IPO year
- 2021
- Market cap
- $657.8K
- Website
- https://www.myndsciences.com
Loading MYNDF…
Loading profile data…Frequently asked questions about MYNDF
What does MYND Life Sciences Inc. (MYNDF) do?
MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the United States, concentrating on therapeutic compounds that possess neuro-anti-inflammatory properties. A signi...
Where does MYNDF trade?
MYND Life Sciences Inc. (MYNDF) trades on the Other OTC.
What sector is MYNDF in?
MYND Life Sciences Inc. (MYNDF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MYND Life Sciences Inc.?
Wilfred A. Jefferies is the chief executive officer of MYND Life Sciences Inc. (MYNDF).
Where is MYND Life Sciences Inc. headquartered?
MYND Life Sciences Inc. is headquartered in Canada.
Does MYNDF pay a dividend?
MYND Life Sciences Inc. (MYNDF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MYNDF go public?
MYND Life Sciences Inc. (MYNDF) completed its initial public offering in 2021.